Cargando…
Aromatic sulphonamides of aziridine-2-carboxylic acid derivatives as novel PDIA1 and PDIA3 inhibitors
In this study, we report a series of newly synthesised sulphonamides of aziridine-2-carboxylic acid (Az-COOH) ester and amide analogues as potent protein disulphide isomerase (PDI, EC 5.3.4.1) inhibitors. The inhibitory activity on PDI was determined against recombinant human PDIA1 and PDIA3 protein...
Autores principales: | Zelencova-Gopejenko, D., Andrianov, V., Domracheva, I., Kanepe-Lapsa, I., Milczarek, M., Stojak, M., Przyborowski, K., Fedak, F. A., Walczak, M., Kramkowski, K., Wietrzyk, J., Chlopicki, S., Kalvins, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120451/ https://www.ncbi.nlm.nih.gov/pubmed/37070480 http://dx.doi.org/10.1080/14756366.2022.2158187 |
Ejemplares similares
-
Comparison of anti-cancer effects of novel protein disulphide isomerase (PDI) inhibitors in breast cancer cells characterized by high and low PDIA17 expression
por: Kurpińska, Anna, et al.
Publicado: (2022) -
A Comparative Analysis of Punicalagin Interaction with PDIA1 and PDIA3 by Biochemical and Computational Approaches
por: Paglia, Giuliano, et al.
Publicado: (2021) -
PDIA2 variant associated with vitiligo
por: Li, Fucheng, et al.
Publicado: (2023) -
ERp57/PDIA3: new insight
por: Chichiarelli, Silvia, et al.
Publicado: (2022) -
Impaired Bone Formation in Pdia3 Deficient Mice
por: Wang, Yun, et al.
Publicado: (2014)